Fondazione Santa Lucia IRCCS — Clinical Trial Site

12 Registered trials

5 Currently recruiting

Organisation

Fondazione Santa Lucia IRCCS

Location

Rome, Italy

Identifier

ORG-100046816

Address

Via Ardeatina 306, 00179, Italy

Departments

#40598:Non-invasive brain stimulation lab
Department of Clinical and Behavioral Neurology
Divisione di Neurologia e Riabilitazione Neurologica
Divisione di Neurologie e Riabilitazione Neurologica
Laboratory of Neuropsychiatry - Department of Clinical and Behavioral Neurology
N/A
Neurobiologia del comportamento
Neurologia e Riabilitazione Neurologica
Psichiatry

Clinical trials at this site (12)

Search interface

Oxytocin for drug relapse prevention Pending

2023-504518-31-01 substance use disorder 4
An Efficacy and Safety Study of Trontinemab in Participants With Early Symptomatic Alzheimer’s Disease (MCI to Mild Dementia Due to AD) Recruiting

2024-518006-40-00 Early Symptomatic Alzheimer’s Disease (MCI to Mild Deme 5 2025-11-13
A Efficacy and Safety Study of Trontinemab in Participants With Early Symptomatic Alzheimer’s Disease (MCI to Mild Dementia Due to AD) Recruiting

2024-518008-33-00 Early Symptomatic Alzheimer’s Disease (MCI to Mild Deme 5 2025-11-12
A Phase 2a, Multi-Center, Randomized, Parallel Group, Double Blind and Placebo-controlled Clinical Trial to Assess Safety and Tolerability a… Recruiting

2024-518563-35-00 Alzheimer's Disease 4 2025-08-25
A research study to compare the antidepressant ability and safety of Samyr® tablets versus placebo tablets as an adjunct to additional antid… Recruiting

2024-513019-29-00 Major Depression Disorder 5 2024-03-22
A Phase 3, prospective, randomized, double-blind, placebo-controlled, parallel group, international, multi-center study of rotigotine in com… Recruiting

2023-504602-11-00 Mild to moderate Alzheimer's disease 5 2023-10-25
A clinical study to investigate the efficacy, safety, and tolerability of continuous subcutaneous ND0612 infusion in comparison to oral trea… Ended

2024-511940-20-00 Parkinson's disease 5 2020-02-05
A study to learn if bepranemab is safe and works in people with early stages of Alzheimer’s Disease Ended

2023-506170-12-00 Alzheimer’s Disease 4 2021-10-18
A clinical trial which runs in multiple countries and aims to evaluate the long-term safety and tolerability of the investigational product … Ended

2024-512123-37-00 Parkinson's disease 5 2021-05-27
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus) Ended

2023-506918-45-00 Mild cognitive impairment (MCI) or mild dementia, both 5 2021-05-17
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE) Ended

2023-506919-18-00 Mild cognitive impairment (MCI) or mild dementia, both 5 2021-05-17
Oxytocin for drug relapse prevention Expired

2023-504518-31-00 substance use disorder 4